tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Gain Therapeutics Inc

GANX
Add to Watchlist
1.680USD
-0.080-4.55%
Close 07-31 16:00（ET）Quotes delayed by 15 min
71.38MMarket Cap
LossP/E TTM

Gain Therapeutics Inc

1.680
-0.080-4.55%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

GANX Financials

See Gain Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Gain Therapeutics Inc Earnings Date

Latest Release
May 11, 2026
EPS / Forecast
-0.13/-0.14
Revenue / Forecast
--/0.00
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.61
31.45%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
15.90%-0.13
11.79%-0.12
10.69%-0.15
54.82%-0.19
29.27%-0.16
56.76%-0.14
54.49%-0.17
31.72%-0.42
48.13%-0.22
20.04%-0.31
---0.37
---0.62
---0.43
---0.39
----
----
----
----
----
----
Revenue
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
-100.00%0.00
22.61%55.18K
-100.00%0.00
-100.00%0.00
6.65%95.10K
754.17%45.01K
--43.21K
--27.34K
1299.23%89.17K
Net Profit
-23.81%-5.61M
-20.42%-4.54M
-17.81%-5.28M
28.66%-5.81M
-12.85%-4.53M
20.23%-3.77M
4.93%-4.49M
-5.92%-8.14M
21.86%-4.01M
-1.06%-4.72M
-3.51%-4.72M
-51.18%-7.69M
-56.98%-5.14M
-45.17%-4.67M
2.26%-4.56M
-42.98%-5.09M
-33.55%-3.27M
---3.22M
---4.66M
-554.57%-3.56M
Net Margin
----
----
----
----
----
----
----
----
----
----
----
----
---9310.11%
----
----
----
----
----
----
----
Gross Margin
----
----
----
----
----
----
----
----
----
----
----
----
--100.00%
----
----
----
----
----
----
----
Debt to assets ratio
-45.81%1.99%
-51.42%1.76%
12.38%3.87%
81.18%4.59%
5.62%3.68%
18.53%3.62%
-10.85%3.44%
-19.99%2.53%
26.40%3.48%
21.87%3.05%
--3.86%
--3.17%
--2.76%
--2.50%
----
----
----
----
----
----
Income Statement
Revenue
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
-100.00%0.00
22.61%55.18K
-100.00%0.00
-100.00%0.00
6.65%95.10K
754.17%45.01K
--43.21K
--27.34K
1299.23%89.17K
Operating profit
-22.52%-5.35M
-34.07%-4.47M
-7.33%-4.79M
37.80%-5.09M
0.19%-4.37M
24.42%-3.33M
8.72%-4.46M
-5.84%-8.18M
16.29%-4.38M
3.38%-4.41M
-2.82%-4.89M
-49.35%-7.73M
-59.03%-5.23M
-42.15%-4.56M
-2.48%-4.75M
-47.28%-5.18M
-33.30%-3.29M
---3.21M
---4.64M
-560.06%-3.51M
Net Profit
-23.81%-5.61M
-20.42%-4.54M
-17.81%-5.28M
28.66%-5.81M
-12.85%-4.53M
20.23%-3.77M
4.93%-4.49M
-5.92%-8.14M
21.86%-4.01M
-1.06%-4.72M
-3.51%-4.72M
-51.18%-7.69M
-56.98%-5.14M
-45.17%-4.67M
2.26%-4.56M
-42.98%-5.09M
-33.55%-3.27M
---3.22M
---4.66M
-554.57%-3.56M
Balance Sheet
Current assets
63.40%18.22M
91.66%22.24M
-23.46%10.52M
-49.80%9.31M
-19.56%11.15M
-34.74%11.60M
3.77%13.74M
7.11%18.54M
-28.26%13.86M
-15.71%17.78M
-45.62%13.24M
-33.00%17.31M
-46.91%19.32M
-44.09%21.09M
-41.40%24.35M
-41.73%25.83M
-23.20%36.39M
--37.72M
--41.55M
--44.34M
Total current liabilities
-22.71%3.89M
-14.29%3.35M
-9.23%4.17M
-20.33%5.20M
0.49%5.03M
-20.98%3.91M
-20.28%4.59M
16.73%6.52M
-2.93%5.00M
19.99%4.95M
33.03%5.76M
63.87%5.59M
22.24%5.15M
61.61%4.13M
21.12%4.33M
39.14%3.41M
81.24%4.22M
--2.55M
--3.58M
--2.45M
Total assets
61.20%18.74M
88.22%22.82M
-23.63%10.97M
-48.77%9.83M
-20.26%11.62M
-34.85%12.12M
1.90%14.37M
5.12%19.20M
-31.63%14.58M
-22.78%18.61M
-50.23%14.10M
-42.74%18.26M
-43.29%21.32M
-38.18%24.10M
-33.45%28.33M
-29.68%31.89M
-21.74%37.60M
--38.99M
--42.56M
--45.35M
Total liabilities
-19.04%4.73M
-11.08%4.25M
-7.22%5.06M
-17.18%6.14M
-1.53%5.84M
-20.67%4.78M
-19.37%5.46M
3.40%7.41M
-4.02%5.94M
15.54%6.03M
19.49%6.77M
47.09%7.17M
7.16%6.18M
25.25%5.22M
12.87%5.66M
22.94%4.87M
61.33%5.77M
--4.17M
--5.02M
--3.96M
Total equity
142.35%14.01M
152.94%18.56M
-33.67%5.91M
-68.64%3.70M
-33.12%5.78M
-41.65%7.34M
21.53%8.91M
6.24%11.78M
-42.91%8.64M
-33.38%12.58M
-67.65%7.33M
-58.94%11.09M
-52.44%15.14M
-45.78%18.88M
-39.64%22.66M
-34.72%27.02M
-28.42%31.83M
--34.82M
--37.55M
--41.39M
Cash Flow Statement
Net operating income
-23.71%-4.73M
-33.69%-4.62M
18.92%-4.93M
11.42%-5.10M
-6.55%-3.82M
38.97%-3.45M
-53.18%-6.08M
-14.64%-5.76M
14.96%-3.59M
-44.97%-5.66M
-20.60%-3.97M
0.59%-5.02M
-72.32%-4.22M
5.83%-3.90M
-50.03%-3.29M
-57.01%-5.05M
12.90%-2.45M
---4.15M
---2.19M
-658.41%-3.22M
Net investment
----
----
----
----
----
-101.38%-43.45K
-100.00%-1.00
-34.25%2.00M
43.27%3.02M
2247.65%3.14M
17002.33%1.93M
120.45%3.05M
27026.26%2.11M
1305.89%133.83K
64.48%-11.41K
-66066.32%-14.89M
72.53%-7.83K
---11.10K
---32.12K
-59318.42%-22.50K
Net financing
-83.13%404.32K
615.62%16.55M
769.67%7.03M
-75.42%2.47M
1744.05%2.40M
-75.81%2.31M
501.37%808.68K
356.75%10.04M
-119.47%-145.80K
44398.94%9.56M
753.38%134.47K
161115.26%2.20M
2072.16%748.91K
-121.69%-21.58K
---20.58K
100.64%1.36K
-100.09%-37.97K
---9.73K
--0.00
-1925.72%-213.79K

FAQs

What are the current assets of Gain Therapeutics Inc?

According to Gain Therapeutics Inc's FY2025 earnings report, its current assets were 22.24M, with a year-on-year change of 91.66.

What are the total assets of Gain Therapeutics Inc?

According to Gain Therapeutics Inc's FY2025 earnings report, its total assets of Gain Therapeutics Inc were 22.82M, with a year-on-year change of 88.22.

What are the total liabilities of Gain Therapeutics Inc?

According to Gain Therapeutics Inc's FY2025 earnings report, its total liabilities of Gain Therapeutics Inc were 4.25M, with a year-on-year change of -11.08.

What is the total equity of Gain Therapeutics Inc?

According to Gain Therapeutics Inc's FY2025 earnings report, its total equity of Gain Therapeutics Inc was 18.56M, with a year-on-year change of 152.94.

What is the net operating income of Gain Therapeutics Inc?

According to Gain Therapeutics Inc's FY2025 earnings report, its net operating income of Gain Therapeutics Inc was -18.71M, with a year-on-year change of 8.06.

What is the net financing of Gain Therapeutics Inc?

According to Gain Therapeutics Inc's FY2025 earnings report, its net financing of Gain Therapeutics Inc was 28.45M, with a year-on-year change of 118.63.

What is the Earnings Per Share (EPS) of Gain Therapeutics Inc?

According to Gain Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.61, with a year-on-year change of 31.45.

What is the net income of Gain Therapeutics Inc?

According to Gain Therapeutics Inc's FY2025 earnings report, its net income was -20.16M, with a year-on-year change of 1.23.

What is the debt-to-asset ratio of Gain Therapeutics Inc?

According to Gain Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 1.76, with a year-on-year change of -51.42.

What is the Return on Equity (ROE) of Gain Therapeutics Inc?

According to Gain Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -155.66, with a year-on-year change of 24.05.

What is the Return on Assets (ROA) of Gain Therapeutics Inc?

According to Gain Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -115.39, with a year-on-year change of 13.12.

What is the operating profit of Gain Therapeutics Inc?

According to Gain Therapeutics Inc's FY2025 earnings report, its operating profit was -18.71M, with a year-on-year change of 8.06.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy